Brozopentyl Sodium

布罗佐喷钠

Report date: 2026/03/12 20:00:16
NME

Base Information

Drug NameBrozopentyl Sodium
Drug Alias NameBZP
ClassificationSmall molecules
Mechanisms of ActionTandem pore domain potassium channels inhibitorsPlatelet aggregation inhibitors
TargetsTandem pore domain potassium channels
Therapy Area/IndicationsIschemic StrokeStroke
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhengzhou University
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhengzhou UniversityHangzhou Ausia Biological Technology Co LtdZhejiang Ausun Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeStroke
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A